Prostate Cancer: Health Education and Screening

(asked on 9th September 2024) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase awareness of (a) prostate cancer risk factors and (b) eligibility for PSA testing of patients aged 50 and above in (i) Cornwall and (ii) England.


Answered by
Andrew Gwynne Portrait
Andrew Gwynne
Parliamentary Under-Secretary (Department of Health and Social Care)
This question was answered on 13th September 2024

NHS England is taking steps to raise awareness of prostate cancer, where there are opportunities to do so. For example, NHS England partners with Cancer Alliances, charities, and local representatives to reach people through projects in the heart of their communities. Cancer Alliances have also been undertaking action to alert at risk groups about prostate cancer, which is determined at a local level and so will vary depending on local needs and priorities.

On 8 January 2024, NHS England also relaunched the Help Us Help You campaign for cancer, designed to increase earlier diagnosis of cancer by reducing barriers to seeking earlier help, as well as increasing body vigilance and knowledge of key red flag symptoms.

Routine Prostate Specific Antigen (PSA) testing is not offered on the National Health Service, although men aged 50 years old or over can ask their general practitioner for a PSA test, even if they do not have symptoms. This applies to anyone aged 50 years old or over with a prostate, in any part of England.

The UK National Screening Committee (UK NSC) does not currently recommend screening for prostate cancer, as the PSA test does not meet the required accuracy for use in a national screening programme. Current methods offer insufficient benefits in relation to harms caused by overdiagnosis, such as invasive investigative procedures and unnecessary treatment, to warrant roll out as an organised screening programme. The UK NSC is due to review prostate cancer again in 2024, and will consider new evidence published since the last review.

Reticulating Splines